NAMD provided written comments to the Health Resources and Services Administration on its proposed rule addressing ceiling prices and manufacturer civil monetary penalties in the 340B drug discount program. Read the full letter here.
Today, the National Association of Medicaid Directors submitted comments to Vicki Wachino, Director, Center for Medicaid & CHIP Services, Centers for Medicare & Medicaid Services at the U.S. Department of Health and Human Services on the proposed rule, Medicaid and Children’s Health Insurance Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies and Revisions […]
This issue brief, developed by the National Association of Medicaid Directors (NAMD) in partnership with the Association of Maternal & Child Health Programs (AMCHP), lays out key background information and the elements of state strategies to address the excessive use of C-sections for low-risk, first time mothers. It is important to note that this resource […]
Today, Matt Salo, executive director of the National Association of Medicaid Directors, gave testimony before the Energy and Commerce Committee, Subcommittee on Health on “Examining the Administration’s Approval of Medicaid Demonstration Projects.” Read the full testimony here.
NAMD submitted comments to the Centers for Medicare and Medicaid Services on the proposed rule on the Application of Mental Health Parity Requirements to Coverage Offered by Medicaid Managed Care Organizations, the Children’s Health Insurance Program (CHIP), and Alternative Benefit Plans. Read the full letter here.
In May 2015, NAMD held a workshop which brought together seven state teams to explore the challenges associated with increasing the delivery of person-centered long-term services and supports (LTSS) in the Medicaid program, with a particular focus on enhancing the delivery of home and community-based services (HCBS). This workshop was made possible by the financial […]
This memo provides an update on the House Energy and Commerce Committee’s 21st Century Cures initiative, which has undergone substantial revision since the release of its first legislative draft in January 2015. Read the full memo here.